Format

Send to

Choose Destination
Card Electrophysiol Clin. 2017 Jun;9(2):295-309. doi: 10.1016/j.ccep.2017.02.011.

Drug Therapy in Adult Congenital Heart Disease.

Author information

1
Department of Cardiology, Arrhythmia Center, Loma Linda University International Heart Institute, 11234 Anderson Street, Loma Linda, CA 92354, USA. Electronic address: TContractor@llu.edu.
2
Electrophysiology, Phoenixville Hospital, 1591 Medical Drive, Pottstown, PA 19464, USA.
3
Department of Cardiology, Arrhythmia Center, Loma Linda University International Heart Institute, 11234 Anderson Street, Loma Linda, CA 92354, USA.

Abstract

Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.

KEYWORDS:

Anticoagulation; Arrhythmia; Congenital heart disease; Drug therapy

PMID:
28457243
DOI:
10.1016/j.ccep.2017.02.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center